Latest S-1 registration statements

NYSE
Pyrophyte Acquisition Corp. II, a Cayman Islands exempted company, filed an amendment to its S-1 registration statement, detailing the structure of its initial public offering of up to 20.125 million units at $10.00 per unit, and outlining its corporate governance, related party agreements, and the framework for its future business combination.
NASDAQ
Blueport Acquisition Ltd has filed an Amendment No. 1 to its S-1 Registration Statement, primarily to update Exhibit 107 related to filing fees for its proposed public offering of units.
NASDAQ
iSpecimen Inc. is offering up to 4,040,404 shares of common stock and pre-funded warrants at $0.99 per share to raise approximately $3.5 million for marketing, technology acquisition, and working capital, despite a going concern warning from its auditors.
NASDAQ
BriaCell Therapeutics Corp. has filed an S-1 registration statement for a public offering of up to 6.8 million units to fund ongoing operations and advance its clinical-stage immunotherapy programs, following a series of positive clinical data readouts for its Bria-IMT and Bria-OTS candidates in metastatic breast cancer.
NYSE
McGraw Hill, a leading global education solutions provider, filed an amended S-1 registration statement for its initial public offering, emphasizing its digital transformation, strong market position, and plans to use IPO proceeds for debt repayment.
A U.S. veterinary hospital operator is seeking to raise up to $5 million through a unit offering to fund working capital and acquisitions, while grappling with significant net losses and a Nasdaq listing deficiency.
NASDAQ
CSLM Digital Asset Acquisition Corp III, a newly formed Special Purpose Acquisition Company (SPAC), filed an amended S-1 registration statement for its $200 million initial public offering, aiming to acquire businesses in the digital asset, Web3, and financial services infrastructure sectors within Frontier Growth Markets.
NASDAQ
Xcel Brands, Inc. is offering up to 1,381,215 shares of common stock and pre-funded warrants to raise approximately $1.9 million, earmarked for brand development and general corporate purposes, following a recent reverse stock split and debt restructuring.
NYSE
Shoulder Innovations, a commercial-stage medical technology company focused on shoulder surgical care, has filed an S-1 registration statement for an initial public offering, showcasing significant revenue growth and strategic plans for market expansion and product innovation.
NASDAQ
60 Degrees Pharmaceuticals, Inc. has filed an S-1 registration statement for a public offering of common stock and warrants to raise approximately $4.2 million, while its auditors have raised substantial doubt about its ability to continue as a going concern.
NASDAQ
StoneBridge Acquisition II Corporation, a blank check company, has filed an amended S-1 registration statement for its initial public offering of $50 million, aiming to acquire international businesses in high-growth sectors across Asia-Pacific and EMEA regions.
OTC.Pink
Windtree Therapeutics, a biotechnology company, filed an S-1/A to register the resale of up to 42.17 million common shares by selling stockholders, while pursuing a new corporate strategy focused on acquiring revenue-generating FDA-approved products and advancing its clinical pipeline, despite significant accumulated deficits and ongoing capital requirements.
NASDAQ
STARRY SEA ACQUISITION CORP, a Cayman Islands-based blank check company, has filed an amended S-1 registration statement for its initial public offering of 5 million units at $10.00 each, revealing substantial immediate dilution for public shareholders and significant risks associated with its management's ties to China.
OID
An agriculture technology company is navigating significant financial challenges, including recurring losses and a Nasdaq delisting, while pursuing new ventures in electric vehicles and Bitcoin mining, necessitating substantial capital raises.
NASDAQ
Emmis Acquisition Corp., a newly formed Cayman Islands blank check company, filed an S-1 registration statement for an initial public offering of 10 million units at $10.00 each, aiming to raise $100 million for a future business combination, while disclosing significant dilution risks for public shareholders.
NASDAQ
Iron Horse Acquisitions Corp. II, a blank check company led by experienced SPAC executives, filed an amended registration statement for its initial public offering of 20 million units at $10.00 each, aiming to raise $200 million for a business combination primarily in the media and entertainment sector.
NASDAQ
Chenghe Acquisition III Co., a blank check company, is launching an initial public offering of 11 million units at $10.00 per unit, aiming to acquire a business in Asian markets or a global company with an Asian focus within 18 months, while facing significant risks related to its China/Hong Kong ties and substantial shareholder dilution.
AMEX
Calidi Biotherapeutics, a clinical-stage biotechnology company, filed an S-1 registration statement for the resale of up to 6.35 million common shares, detailing its novel oncolytic virus platforms, recent management changes, and persistent financial challenges including substantial operating losses and a going concern warning.
NASDAQ
BioVie Inc. has filed a registration statement for a public offering of units and pre-funded units, aiming to raise capital for its clinical-stage drug development programs while facing significant dilution and potential Nasdaq delisting risks.
OQB
Jones Soda Co. has filed an S-1 registration statement for a public offering of common stock, aiming to raise capital for working capital and strategic growth initiatives while navigating recurring operational losses and a significant divestiture of its THC cannabis business.
YHD
Spectral IP, Inc., an intellectual property investment and monetization firm, has filed an S-1/A registration statement for an initial public offering of 3,750,000 shares of common stock on the Nasdaq Capital Market, aiming to raise approximately $12.2 million in net proceeds despite reporting significant losses and no revenue since its inception in 2024.
NASDAQ
Quantum Computing Inc. has filed an S-1 registration statement to allow selling stockholders to resell up to 14,035,089 shares of common stock, which were recently issued in a private placement that generated approximately $200 million in gross proceeds for the company.
NYSE
Ambiq Micro, a pioneer in ultra-low power semiconductor solutions for edge AI, has filed for an initial public offering to fund its growth strategy, despite a history of net losses and significant customer concentration.
General Enterprise Ventures, Inc. (GEVI) is pursuing a public offering of 1,250,000 common shares at an assumed price of $12.00 per share to raise approximately $15 million, contingent on listing its environmentally sustainable fire retardant product on NYSE American.
Reliance Global Group, Inc. filed an Amendment No. 1 to its S-1 Registration Statement to include previously omitted exhibits and register up to 4,568,455 shares of common stock for resale by selling stockholders.
NASDAQ
Xcel Brands, Inc. is launching a best-efforts public offering of up to 1,381,215 shares of common stock and pre-funded warrants to raise approximately $1.9 million in net proceeds, while navigating significant debt obligations and a strategic reduction in its IM Topco LLC equity interest.
Entero Therapeutics, Inc. is seeking to raise approximately $4 million through a public offering of common stock and pre-funded warrants to fund operations and advance its lead drug candidate, Adrulipase, while navigating severe financial constraints and the rescission of a recent merger.
NASDAQ
DevvStream Corp., a newly public environmental asset generation company, reported substantial net losses and a critical working capital deficit, triggering a Nasdaq minimum bid price non-compliance notice, while actively seeking significant capital to fund its operations and strategic initiatives.
OTC.Pink
First Choice Healthcare Solutions, Inc. is undergoing a significant strategic transformation, shifting from its legacy orthopedic business to a national network of primary care and wellness clinics, supported by a new public offering of Series D Convertible Preferred Stock and warrants aiming to raise $10 million.
AMEX
Healthy Choice Wellness Corp. has filed an S-1 registration statement for the resale of 2,355,072 shares of Class A common stock, signaling a move to enhance liquidity for selling stockholders while the company continues to expand its natural grocery and wellness footprint.